SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ ...
SAN DIEGO--(BUSINESS WIRE)--Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and disease, ...
17d
Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care
Fox Chase Cancer Center and Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced that ...
"During my decade at Illumina Ventures, I evaluated countless genomics innovations, yet Arima’s approach stands out for its ability to illuminate aspects of the genome most tests never see," said ...
Arima Genomics is advancing the life sciences through the power of three-dimentional genomes. They develop innovative solutions that drive discovery in genomics and improve human health. Arima ...
The ARIMA statement applies the X-11-ARIMA method to the series specified in the VAR statement. This method uses an ARIMA model estimated from the original data to extend the series one or more years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results